A graduate of the University of North Texas Health Science Center, Dr
GLP-1 receptor activation signals the brain to reduce hunger, stimulates insulin secretion in response to meals, and slows gastric emptying so you feel full longer
Zepbound affects two receptors, the GLP-1 and GIP, whereas Wegovy only affects the GLP-1 receptor, says Mir Ali, MD, a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, California
(If no, stay at current dose) Am I below my goal weight
Rather than increasing medication on a fixed schedule, Nooms physician-designed protocol adjusts dosing based on each patient's individual progress and response
In 2021, a peak dose of 2.4mg/weekly was authorized for adults under the brand name Wegovy, with its approval extending to adolescent weight management in 2023 [12, 15]